These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 7948733

  • 1. Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2.
    Wilkes BC, Schiller PW.
    Biopolymers; 1994 Sep; 34(9):1213-9. PubMed ID: 7948733
    [Abstract] [Full Text] [Related]

  • 2. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
    Wilkes BC, Schiller PW.
    Biopolymers; 1995 Sep; 37(6):391-400. PubMed ID: 8589244
    [Abstract] [Full Text] [Related]

  • 3. The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bonds.
    Wilkes BC, Nguyen TM, Weltrowska G, Carpenter KA, Lemieux C, Chung NN, Schiller PW.
    J Pept Res; 1998 May; 51(5):386-94. PubMed ID: 9606018
    [Abstract] [Full Text] [Related]

  • 4. Conformation-activity relationships of cyclic dermorphin analogues.
    Wilkes BC, Schiller PW.
    Biopolymers; 1990 Jan; 29(1):89-95. PubMed ID: 2158362
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the bioactive form of linear peptide antagonists at the omega-opioid receptor.
    Chao TM, Perez JJ, Loew GH.
    Biopolymers; 1996 Jun; 38(6):759-68. PubMed ID: 8652796
    [Abstract] [Full Text] [Related]

  • 6. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
    Salvadori S, Attila M, Balboni G, Bianchi C, Bryant SD, Crescenzi O, Guerrini R, Picone D, Tancredi T, Temussi PA.
    Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Opioid diketopiperazines: refinement of the delta opioid antagonist pharmacophore.
    Bryant SD, Balboni G, Guerrini R, Salvadori S, Tomatis R, Lazarus LH.
    Biol Chem; 1997 Feb; 378(2):107-14. PubMed ID: 9088539
    [Abstract] [Full Text] [Related]

  • 9. N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.
    Weltrowska G, Nguyen TM, Chung NN, Wilkes BC, Schiller PW.
    Bioorg Med Chem Lett; 2013 Sep 15; 23(18):5082-5. PubMed ID: 23932788
    [Abstract] [Full Text] [Related]

  • 10. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
    Schiller PW, Weltrowska G, Nguyen TM, Lemieux C, Chung NN, Marsden BJ, Wilkes BC.
    J Med Chem; 1991 Oct 15; 34(10):3125-32. PubMed ID: 1656045
    [Abstract] [Full Text] [Related]

  • 11. X-ray structure of Tyr-D-Tic-Phe-Phe-NH2 (D-TIPP-NH2), a highly potent mu-receptor selective opioid agonist. Comparison with proposed model structures.
    Flippen-Anderson JL, Deschamps JR, George C, Reddy PA, Lewin AH, Brine GA, Sheldrick G, Nikiforovich G.
    J Pept Res; 1997 May 15; 49(5):384-93. PubMed ID: 9211219
    [Abstract] [Full Text] [Related]

  • 12. [Aladan3]TIPP: a fluorescent delta-opioid antagonist with high delta-receptor binding affinity and delta selectivity.
    Chen H, Chung NN, Lemieux C, Zelent B, Vanderkooi JM, Gryczynski I, Wilkes BC, Schiller PW.
    Biopolymers; 2005 May 15; 80(2-3):325-31. PubMed ID: 15614807
    [Abstract] [Full Text] [Related]

  • 13. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands.
    Lomize AL, Pogozheva ID, Mosberg HI.
    Biopolymers; 1996 Feb 15; 38(2):221-34. PubMed ID: 8589255
    [Abstract] [Full Text] [Related]

  • 14. Role of hydrophobic substituents in the interaction of opioid Tyr-Tic dipeptide analogs with dodecylphosphocholine micelles. Molecular partitioning in model membrane systems.
    Carpenter KA, Wilkes BC, Weltrowska G, Schiller PW.
    Eur J Biochem; 1996 Nov 01; 241(3):756-64. PubMed ID: 8944763
    [Abstract] [Full Text] [Related]

  • 15. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
    Schiller PW, Weltrowska G, Berezowska I, Nguyen TM, Wilkes BC, Lemieux C, Chung NN.
    Biopolymers; 1999 Nov 01; 51(6):411-25. PubMed ID: 10797230
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI, Lomize AL, Wang C, Kroona H, Heyl DL, Sobczyk-Kojiro K, Ma W, Mousigian C, Porreca F.
    J Med Chem; 1994 Dec 09; 37(25):4371-83. PubMed ID: 7996549
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Selective opioid dipeptides.
    Temussi PA, Salvadori S, Amodeo P, Bianchi C, Guerrini R, Tomatis R, Lazarus LH, Picone D, Tancredi T.
    Biochem Biophys Res Commun; 1994 Feb 15; 198(3):933-9. PubMed ID: 8117299
    [Abstract] [Full Text] [Related]

  • 20. Conformational analysis of potent and very selective delta opioid dipeptide antagonists.
    Amodeo P, Balboni G, Crescenzi O, Guerrini R, Picone D, Salvadori S, Tancredi T, Temussi PA.
    FEBS Lett; 1995 Dec 27; 377(3):363-7. PubMed ID: 8549756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.